Meeting scalability challenges for autologous cell-based manufacturing with automated closed-system solutions

Dr Giulia Detela is Process Design Manager at VivaBioCell S.p.A., a company of the NantWorks group, which develops novel automated systems for cell-based product manufacturing. She supports the EU/US tech transfer activities related to cell manufacturing for regenerative medicine and immunotherapy applications. She also ensures that products and processes are compliant to regulatory requirements, performs risk and costs analyis, whilst providing support to the Business Development activities. Giulia was previously a Process Development Scientist at The Cell and Gene Therapy Catapult, supporting the development of candidate advanced therapy products and associated CMC quality requirements. She obtained her PhD in 2015 with a project aimed at discovering strategies to enhance the engraftment and angiogenic potential of human mesenchymal stromal cells within ischemic tissues at the Regenerative Medicine and Bioprocessing Unit of the Department of Biochemical Engineering at University College London (UCL).